Downregulation of signalling molecules involved in angiogenesis of prostate cancer cell line (PC-3) by kombucha (lyophilized)

Biomedicine and Preventive Nutrition

Volumn 3, Issue 1, 2013, Pages 53-58

  Srihari, Thummala ^a   Arunkumar, Ramachandran ^b   Arunakaran, Jagadeesan ^b   Satyanarayana, Uppala ^c  

^a Siddhartha Medical College   (India)

^b UNIVERSITY OF MADRAS   (India)

^c Dr Pinnamaneni Siddhartha Institute of Medical Sciences and Research Foundation   (India)

Author keywords

Angiogenesis; Cell viability; Kombucha; Probiotics; Prostate cancer; Wound healing assay

Indexed keywords

ANDROGEN; CYCLOOXYGENASE 2; GELATINASE A; GELATINASE B; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 8; MATRIX METALLOPROTEINASE; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; BEVERAGE; CANCER CELL CULTURE; CANCER INHIBITION; CELL MIGRATION; CELL STRAIN PC 3; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KOMBUCHA; MALE; PRIORITY JOURNAL; PROSTATE CANCER; SIGNAL TRANSDUCTION; TEA;

CAMELLIA SINENSIS; FUNGI;

EID: 84875252754     PISSN: 22105239     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bionut.2012.08.001     Document Type: Article

References (32)

1. Rini B.I., Small E.J. An update on prostate cancer. Curr Opin Oncol 2001, 13:204-211.
2. Jemal A., Thomas A., Murray T., et al. Cancer statistics. CA Cancer J Clin 2004, 54:8-29.
3. Folkman J. Angiogenesis-dependent diseases. Semin Oncol 2001, 28:36-42.
4. Liekens S.D., Clercq E., Neyts J. Angiogenesis: regulators and clinical applications. Biochem Pharmacol 2001, 61:253-270.
5. Park K.Y., Lee H.J., Jeong S.J., Lee H.J., Kim H.S., Kim S.H., et al. 1,2,3,4,6-Penta-O-galloly-beta-D-glucose suppresses hypoxia-induced accumulation of hypoxia-inducible factor-1 and signaling in LNCaP prostate cancer cells. Biol Pharm Bull 2010, 33:1835-1840.
6. Minchenko A., Bauer T., Salceda S., Caro J. Hypoxic stimulation of vascular endothelial growth factor expression in vivo and in vitro. Lab Invest 1994, 71:374-379.
7. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992, 359:843-845.
8. Matsuo Y., Ochi N., Sawai H., Yasuda A., Takahashi H., Funahashi H., et al. CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer. Int J Cancer 2009, 124:853-861.
9. Kosaka T., Miyata A., Ihara H., et al. Characterization of the human gene (PTGS2) encoding prostaglandinendoperoxide synthase 2. Eur J Biochem 1994, 221:889-897.
10. Vadlamudi R., Mandal M., Adam L., et al. Regulation of cyclooxygenase-2 pathway by HER2 receptor. Oncogene 1999, 18:305-314.
11. Dang C.T., Shapiro C.L., Hudis C.A. Potential role of selective COX-2 inhibitors in cancer management. Oncology 2002, 16:30-36.
12. Wojtowicz-Praga S., Low J., Marshall J., et al. Phase I trial of a novel matrix metalloproteinase inhibitor batimistat (BB-94) in patients with advanced cancer. Invest New Drug 1996, 14:193-202.
13. Brown P.D. Matrix metalloproteinase inhibitors in the treatment of cancer. Med Oncol 1997, 14:1-10.
14. Sreeramulu G., Zhu Y., Knol W. Kombucha fermentation and its antimicrobial activity. J Agric Food Chem 2000, 48:2589-2594.
15. Jayabaln R., Chen P.N., Hsieh Y.S., Prabhakaran K., Pitchai P., Marimuthu S., et al. Effect of solvent fractions of kombucha on viability and invasiveness of cancer-characterization of dimethyl 2-(2-hydroxy-2-methoxypropylidine) malonate and vitexin. Indian J Biotech 2011, 10:75-82.
16. Pepper M.S., Ferrara N., Orci L., Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor type 1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991, 181:902-908.
17. Mandriota S., Montesano R., Orci L., Seghezzi G., Vassalli J.D., Ferrara N., et al. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. J Biol Chem 1995, 270:9709-9716.
18. Bussolino F., Mantovani A., Persico G. Molecular mechanisms of blood vessel formation. Trends Biochem Sci 1997, 22:251-256.
19. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003, 9:653-660.
20. Fasciani A., D'Ambrogio G., Bocci G., Monti M., Genazzani A.R., Artini P.G. High concentrations of the vascular endothelial growth factor and interleukin-8 in ovarian endometriomata. Mol Hum Reprod 2000, 6:50-54.
21. Fujimoto J., Sakaguchi H., Aoki I., Tamaya T. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000, 60:2632-2635.
22. Uotila P., Valve E., Martikainen P., et al. Increased expression of cyclooxygenase-2 and nitric oxide synthase-2 in human prostate cancer. Urol Res 2001, 29:23-28.
23. Matrisian L.M. Metalloproteinases and their inhibitors in matrix remolding. Trends Genet 1990, 6:121-125.
24. Kerr L.D., Holt J.T., Matrisian L.M. Growth factors regulate transin gene expression by c-fos and c-fos independent pathways. Science 1988, 242:1424-1427.
25. McDonnel S.E., Fingleton B. Role of matrix metalloproteinase in invasion and metastasis: biology, diagnosis and inhibitors. Cytotechnology 1993, 12:367-384.
26. Bredin C.G., Liu Z., Klominek J. Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines. Anticancer Res 2003, 23:4877-4884.
27. Zhang D., Samani A.A., Brodt P. The role of the IGF-I receptor in the regulation of matrix metalloproteinases, tumor invasion and metastasis. Horm Metab Res 2003, 35:802-808.
28. Fuller R. History and development of probiotics, The scientific basis 1992, Chapman & Hall, London.
29. Marteau P., Rambaud J.C. Potential of using lactic bacteria for therapy and immunomodulation in man. FEMS Microbiol Rev 1993, 12:207-220.
30. Dufresne C., Farnworth E. Tea, Kombucha, and a health: a review. Food Res Int 2000, 33:409-421.
31. Loncar E.S., Malbasa R.V., Kolarov L.A. Metabolic activity of tea fungus on molasses as a source of carbon. APTEFF 2001, 32:21-25.
32. Pauline T., Dipti P., Anju B., Kavimani S., Sharma S.K., Kain A.K., et al. Studies on toxicity, anti-stress and hepatoprotective properties of kombucha. Biomed Environ Sci 2001, 14:207-213.